Universe Pharmaceuticals (UPC) Construction in Progress (2021 - 2024)
Universe Pharmaceuticals (UPC) posted Construction in Progress of $9.2 million for Q1 2024, up 1.46% sequentially from $9.1 million in Q3 2023, and down 4.5% YoY from $9.7 million in Q2 2023.
Universe Pharmaceuticals (UPC) Construction in Progress (2021 - 2024) Analysis & Trends
Universe Pharmaceuticals has reported Construction in Progress for 4 years, with the latest figure at $9.2 million in Q1 2024.
- Quarterly Construction in Progress fell 4.5% year-over-year to $9.2 million in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $9.2 million (down 4.5% YoY) and the FY2023 annual result came in at $9.1 million, down 2.5% from the prior year.
- Construction in Progress rose to $9.2 million in Q1 2024 per UPC's latest filing, from $9.1 million in the prior quarter.
- Over five years, Construction in Progress peaked at $10.7 million in Q3 2021 and troughed at $9.1 million in Q3 2023.
- A 4-year average of $9.7 million and a median of $9.5 million in 2022 frame the typical range for Construction in Progress.
- The sharpest annual moves came in 2022 and 2023: Construction in Progress fell 12.94% in 2022, then fell 2.5% in 2023.
- Over 4 years, Construction in Progress stood at $10.7 million in 2021, then dropped by 12.94% to $9.3 million in 2022, then declined by 2.5% to $9.1 million in 2023, then gained by 1.46% to $9.2 million in 2024.
- According to Business Quant data, Construction in Progress over the past three periods registered $9.2 million, $9.1 million, and $9.7 million for Q1 2024, Q3 2023, and Q1 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Universe Pharmaceuticals | 3.04 Mn | -26.01 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 9.23 Mn |
| Sep 30, 2023 | 9.09 Mn |
| Mar 31, 2023 | 9.66 Mn |
| Sep 30, 2022 | 9.33 Mn |
| Mar 31, 2022 | 10.45 Mn |
| Sep 30, 2021 | 10.71 Mn |